Key facts
- This page summarizes Peter D. Haytaian's Form 4 filing for Elevance Health, Inc. (ELV).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Mar 2026, 16:57.
Peter D. Haytaian - 02 Mar 2026 Form 4 Insider Report for Elevance Health, Inc. (ELV)
- Reporting relationship
- EVP & Pres Carelon & CarelonRx
- Issuer ticker
- ELV
- Reported as of
- 02 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Mar 2026, 16:57:53 UTC
- Prior SEC filing
- 05 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kathleen S. Kiefer, Attorney in fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Peter D. Haytaian filed Form 4 for Elevance Health, Inc. (ELV) on 04 Mar 2026.
Change
- Previous filing in this sequence was filed on 05 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001608538
Primary reporting owner
Haytaian Peter D
- Relationship
- EVP & Pres Carelon & CarelonRx
- Address
- 220 VIRGINIA AVENUE, INDIANAPOLIS
- Signature
- /s/ Kathleen S. Kiefer, Attorney in fact
- Signature date
- 04 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ELV
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -1,201
- Change %
- -4.6%
- Price
- $294.07*
- Shares after
- 24,803
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
ELV
transaction
Common Stock
Award
- Transaction value
- Shares
- +2,865
- Change %
- +12%
- Price
- $0.000000*
- Shares after
- 27,668
- Date
- 02 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
ELV
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -446
- Change %
- -1.6%
- Price
- $284.03*
- Shares after
- 27,222
- Date
- 03 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Footnote F2
Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.